

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cobalamin metabolic process (GO:0009235) | 8.05197593 |
| 2 | transcytosis (GO:0045056) | 7.76286207 |
| 3 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 7.50676218 |
| 4 | regulation of phospholipase A2 activity (GO:0032429) | 7.41310300 |
| 5 | peptidyl-proline hydroxylation (GO:0019511) | 7.34889465 |
| 6 | intestinal absorption (GO:0050892) | 7.21044731 |
| 7 | sterol catabolic process (GO:0016127) | 6.94769268 |
| 8 | cholesterol catabolic process (GO:0006707) | 6.94769268 |
| 9 | negative regulation of digestive system process (GO:0060457) | 6.85697641 |
| 10 | cysteine metabolic process (GO:0006534) | 6.53239588 |
| 11 | glycolipid catabolic process (GO:0019377) | 6.51505879 |
| 12 | negative regulation of protein oligomerization (GO:0032460) | 6.25242944 |
| 13 | negative regulation of gluconeogenesis (GO:0045721) | 6.17662032 |
| 14 | branched-chain amino acid catabolic process (GO:0009083) | 6.11941005 |
| 15 | positive regulation of glycolytic process (GO:0045821) | 6.10123849 |
| 16 | proline biosynthetic process (GO:0006561) | 6.04539086 |
| 17 | membrane lipid catabolic process (GO:0046466) | 5.95675388 |
| 18 | valine metabolic process (GO:0006573) | 5.89330814 |
| 19 | regulation of glucokinase activity (GO:0033131) | 5.88564883 |
| 20 | regulation of hexokinase activity (GO:1903299) | 5.88564883 |
| 21 | Golgi transport vesicle coating (GO:0048200) | 5.84392670 |
| 22 | COPI coating of Golgi vesicle (GO:0048205) | 5.84392670 |
| 23 | protein hydroxylation (GO:0018126) | 5.65906367 |
| 24 | positive regulation of respiratory burst (GO:0060267) | 5.57411664 |
| 25 | fatty acid homeostasis (GO:0055089) | 5.43672869 |
| 26 | branched-chain amino acid metabolic process (GO:0009081) | 5.38598761 |
| 27 | ceramide catabolic process (GO:0046514) | 5.24658837 |
| 28 | negative regulation of acute inflammatory response (GO:0002674) | 5.14564709 |
| 29 | nitric oxide mediated signal transduction (GO:0007263) | 5.00268398 |
| 30 | cellular modified amino acid catabolic process (GO:0042219) | 4.92365623 |
| 31 | protein maturation by protein folding (GO:0022417) | 4.87664357 |
| 32 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.85307257 |
| 33 | serine family amino acid biosynthetic process (GO:0009070) | 4.80220835 |
| 34 | positive regulation of protein autophosphorylation (GO:0031954) | 4.79711984 |
| 35 | signal peptide processing (GO:0006465) | 4.79636174 |
| 36 | negative regulation of hormone biosynthetic process (GO:0032353) | 4.76268079 |
| 37 | leukotriene biosynthetic process (GO:0019370) | 4.74126700 |
| 38 | zinc ion transport (GO:0006829) | 4.73173893 |
| 39 | lactate metabolic process (GO:0006089) | 4.66272642 |
| 40 | positive regulation of nuclease activity (GO:0032075) | 4.64700217 |
| 41 | negative regulation of glycogen metabolic process (GO:0070874) | 4.64689391 |
| 42 | insulin secretion (GO:0030073) | 4.61190780 |
| 43 | mitochondrial calcium ion transport (GO:0006851) | 4.59985695 |
| 44 | positive regulation of peptide hormone secretion (GO:0090277) | 4.58141305 |
| 45 | chemosensory behavior (GO:0007635) | 4.56045355 |
| 46 | positive regulation of insulin secretion (GO:0032024) | 4.51526011 |
| 47 | response to endoplasmic reticulum stress (GO:0034976) | 4.50305596 |
| 48 | GDP-mannose metabolic process (GO:0019673) | 4.46519471 |
| 49 | negative regulation of hormone metabolic process (GO:0032351) | 4.45813132 |
| 50 | type B pancreatic cell development (GO:0003323) | 4.44699314 |
| 51 | homocysteine metabolic process (GO:0050667) | 4.44164370 |
| 52 | aspartate family amino acid catabolic process (GO:0009068) | 4.43353738 |
| 53 | intestinal epithelial cell development (GO:0060576) | 4.43108084 |
| 54 | cellular ketone body metabolic process (GO:0046950) | 4.40276297 |
| 55 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.39949644 |
| 56 | positive regulation of peptide secretion (GO:0002793) | 4.39286622 |
| 57 | maintenance of protein localization in organelle (GO:0072595) | 4.38419305 |
| 58 | neutrophil mediated immunity (GO:0002446) | 4.32324391 |
| 59 | positive regulation of heat generation (GO:0031652) | 4.31592237 |
| 60 | cellular response to unfolded protein (GO:0034620) | 4.30670582 |
| 61 | 4-hydroxyproline metabolic process (GO:0019471) | 4.28246119 |
| 62 | regulation of nuclease activity (GO:0032069) | 4.24699673 |
| 63 | proline metabolic process (GO:0006560) | 4.17843585 |
| 64 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 4.17709510 |
| 65 | cellular response to topologically incorrect protein (GO:0035967) | 4.14709892 |
| 66 | regulation of fever generation (GO:0031620) | 4.13917549 |
| 67 | positive regulation of glycogen biosynthetic process (GO:0045725) | 4.06733439 |
| 68 | ER-nucleus signaling pathway (GO:0006984) | 4.03821824 |
| 69 | glutamine metabolic process (GO:0006541) | 4.00739071 |
| 70 | COPII vesicle coating (GO:0048208) | 4.00032952 |
| 71 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.98144923 |
| 72 | antibacterial humoral response (GO:0019731) | 3.91797231 |
| 73 | glandular epithelial cell differentiation (GO:0002067) | 3.90634369 |
| 74 | serine family amino acid metabolic process (GO:0009069) | 3.87456568 |
| 75 | positive regulation of response to nutrient levels (GO:0032109) | 3.87407717 |
| 76 | positive regulation of response to extracellular stimulus (GO:0032106) | 3.87407717 |
| 77 | L-serine metabolic process (GO:0006563) | 3.84518691 |
| 78 | ketone body metabolic process (GO:1902224) | 3.84289342 |
| 79 | positive regulation of macroautophagy (GO:0016239) | 3.82725506 |
| 80 | L-phenylalanine catabolic process (GO:0006559) | 3.81704163 |
| 81 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.81704163 |
| 82 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.79463521 |
| 83 | detection of calcium ion (GO:0005513) | 3.77783283 |
| 84 | ER overload response (GO:0006983) | 3.77726841 |
| 85 | inositol phosphate catabolic process (GO:0071545) | 3.70521645 |
| 86 | response to lipoprotein particle (GO:0055094) | 3.70355409 |
| 87 | creatine metabolic process (GO:0006600) | 3.66302241 |
| 88 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.62960936 |
| 89 | L-phenylalanine metabolic process (GO:0006558) | 3.62960936 |
| 90 | antimicrobial humoral response (GO:0019730) | 3.62785225 |
| 91 | positive regulation of glycogen metabolic process (GO:0070875) | 3.60160532 |
| 92 | coenzyme catabolic process (GO:0009109) | 3.57531322 |
| 93 | steroid catabolic process (GO:0006706) | 3.57513347 |
| 94 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 3.57067683 |
| 95 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.55967499 |
| 96 | nucleoside diphosphate catabolic process (GO:0009134) | 3.54027548 |
| 97 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.53369699 |
| 98 | response to unfolded protein (GO:0006986) | 3.52086118 |
| 99 | macroautophagy (GO:0016236) | 3.51473216 |
| 100 | endocrine pancreas development (GO:0031018) | 3.51405988 |
| 101 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.50868798 |
| 102 | cell redox homeostasis (GO:0045454) | 3.49206095 |
| 103 | xenobiotic catabolic process (GO:0042178) | 3.48863407 |
| 104 | peptidyl-asparagine modification (GO:0018196) | 3.48543061 |
| 105 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.48447705 |
| 106 | regulation of insulin secretion (GO:0050796) | 3.48236757 |
| 107 | icosanoid secretion (GO:0032309) | 3.46101364 |
| 108 | arachidonic acid secretion (GO:0050482) | 3.46101364 |
| 109 | positive regulation of hormone secretion (GO:0046887) | 3.43766756 |
| 110 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.42264155 |
| 111 | response to topologically incorrect protein (GO:0035966) | 3.41868264 |
| 112 | sulfur amino acid biosynthetic process (GO:0000097) | 3.39263909 |
| 113 | cellular zinc ion homeostasis (GO:0006882) | 3.38582763 |
| 114 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.37399500 |
| 115 | sphingolipid catabolic process (GO:0030149) | 3.37228457 |
| 116 | glycerophospholipid catabolic process (GO:0046475) | 3.37008204 |
| 117 | biotin metabolic process (GO:0006768) | 3.35790985 |
| 118 | glycine metabolic process (GO:0006544) | 3.30049949 |
| 119 | regulation of heat generation (GO:0031650) | 3.28383360 |
| 120 | myeloid leukocyte mediated immunity (GO:0002444) | 3.27047126 |
| 121 | mitochondrion distribution (GO:0048311) | 3.24642735 |
| 122 | regulation of peptide hormone secretion (GO:0090276) | 3.23558665 |
| 123 | inositol phosphate dephosphorylation (GO:0046855) | 3.23402549 |
| 124 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.23402549 |
| 125 | retinal metabolic process (GO:0042574) | 3.23338411 |
| 126 | polyol catabolic process (GO:0046174) | 3.22914658 |
| 127 | zinc ion homeostasis (GO:0055069) | 3.21185851 |
| 128 | protein N-linked glycosylation (GO:0006487) | 3.21095644 |
| 129 | peptide hormone processing (GO:0016486) | 3.20982605 |
| 130 | regulation of glycolytic process (GO:0006110) | 3.20250539 |
| 131 | respiratory chain complex IV assembly (GO:0008535) | 3.19797335 |
| 132 | regulation of protein glycosylation (GO:0060049) | 3.17420691 |
| 133 | regulation of peptide secretion (GO:0002791) | 3.15282443 |
| 134 | peptide hormone secretion (GO:0030072) | 3.14217646 |
| 135 | positive regulation of vasodilation (GO:0045909) | 3.14073359 |
| 136 | alpha-amino acid biosynthetic process (GO:1901607) | 3.12242207 |
| 137 | negative regulation of neurological system process (GO:0031645) | 3.10898876 |
| 138 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175) | 3.10749622 |
| 139 | phenylpropanoid metabolic process (GO:0009698) | 3.09728412 |
| 140 | glandular epithelial cell development (GO:0002068) | 3.09617712 |
| 141 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.08724533 |
| 142 | regulation of energy homeostasis (GO:2000505) | 3.08406583 |
| 143 | response to glucose (GO:0009749) | 3.05932980 |
| 144 | response to hepatocyte growth factor (GO:0035728) | 3.05527348 |
| 145 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.05527348 |
| 146 | cellular response to vitamin D (GO:0071305) | 3.04753995 |
| 147 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.02712389 |
| 148 | zinc ion transmembrane transport (GO:0071577) | 3.01615529 |
| 149 | peptide secretion (GO:0002790) | 3.00312498 |
| 150 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.00228728 |
| 151 | cellular protein catabolic process (GO:0044257) | 2.99668974 |
| 152 | innate immune response in mucosa (GO:0002227) | 2.99219917 |
| 153 | regulation of protein autophosphorylation (GO:0031952) | 2.97306044 |
| 154 | keratinocyte development (GO:0003334) | 2.96092735 |
| 155 | regulation of oxidative stress-induced cell death (GO:1903201) | 2.96080999 |
| 156 | sulfur amino acid catabolic process (GO:0000098) | 2.94983304 |
| 157 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.94461518 |
| 158 | peptidyl-proline modification (GO:0018208) | 2.94443002 |
| 159 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.93876360 |
| 160 | response to hexose (GO:0009746) | 2.92083589 |
| 161 | aspartate family amino acid metabolic process (GO:0009066) | 2.91850337 |
| 162 | peptide catabolic process (GO:0043171) | 2.90313950 |
| 163 | digestive system process (GO:0022600) | 2.89614534 |
| 164 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.88750710 |
| 165 | regulation of autophagic vacuole assembly (GO:2000785) | 2.88601851 |
| 166 | lysine catabolic process (GO:0006554) | 2.88246890 |
| 167 | lysine metabolic process (GO:0006553) | 2.88246890 |
| 168 | regulation of digestive system process (GO:0044058) | 2.86552948 |
| 169 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.85267859 |
| 170 | regulation of hormone secretion (GO:0046883) | 2.82324917 |
| 171 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.81763633 |
| 172 | epithelial cell fate commitment (GO:0072148) | 2.76796828 |
| 173 | cellular response to zinc ion (GO:0071294) | 2.75629011 |
| 174 | response to monosaccharide (GO:0034284) | 2.75498699 |
| 175 | regulation of vacuole organization (GO:0044088) | 2.74449688 |
| 176 | regulation of respiratory burst (GO:0060263) | 2.71654671 |
| 177 | regulation of acrosome reaction (GO:0060046) | 2.68742210 |
| 178 | hormone secretion (GO:0046879) | 2.63964294 |
| 179 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.63260949 |
| 180 | kidney morphogenesis (GO:0060993) | 2.62408916 |
| 181 | regulation of oxidative phosphorylation (GO:0002082) | 2.61850753 |
| 182 | intestinal cholesterol absorption (GO:0030299) | 16.1377979 |
| 183 | exocrine pancreas development (GO:0031017) | 15.7685929 |
| 184 | digestion (GO:0007586) | 13.7730311 |
| 185 | protein retention in ER lumen (GO:0006621) | 12.6221946 |
| 186 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 11.8905216 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 8.17247086 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.00050495 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.87466180 |
| 4 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.61776712 |
| 5 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.45943538 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.10033487 |
| 7 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.69418710 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.69267805 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.67716125 |
| 10 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.61542728 |
| 11 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.57736431 |
| 12 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.51768660 |
| 13 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.44172667 |
| 14 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.38447061 |
| 15 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.35580823 |
| 16 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.35580823 |
| 17 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.35580823 |
| 18 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.32086862 |
| 19 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.28864668 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.15147735 |
| 21 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.12547166 |
| 22 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 2.11827685 |
| 23 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.03972977 |
| 24 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.03006642 |
| 25 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.01833281 |
| 26 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.00536454 |
| 27 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.97881922 |
| 28 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.89522276 |
| 29 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.84028124 |
| 30 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.81059913 |
| 31 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.79331799 |
| 32 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.78363158 |
| 33 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.76513504 |
| 34 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.74865464 |
| 35 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.71599014 |
| 36 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.70534909 |
| 37 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.68100806 |
| 38 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.67930256 |
| 39 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.64113032 |
| 40 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.62828618 |
| 41 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.59940950 |
| 42 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.58858219 |
| 43 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.58767349 |
| 44 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.57195430 |
| 45 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.54600949 |
| 46 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.54093851 |
| 47 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.51305128 |
| 48 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.50203954 |
| 49 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.49258565 |
| 50 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.45382227 |
| 51 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.42722562 |
| 52 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.42287356 |
| 53 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.41736506 |
| 54 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.41497580 |
| 55 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.41109744 |
| 56 | GATA1_22025678_ChIP-Seq_K562_Human | 1.40422973 |
| 57 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.37637425 |
| 58 | AR_25329375_ChIP-Seq_VCAP_Human | 1.37432442 |
| 59 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.36539640 |
| 60 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.36539640 |
| 61 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.36224272 |
| 62 | P300_19829295_ChIP-Seq_ESCs_Human | 1.36047536 |
| 63 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.35385669 |
| 64 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.34493920 |
| 65 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.34399375 |
| 66 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.32585831 |
| 67 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.31879614 |
| 68 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.30064871 |
| 69 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.29127087 |
| 70 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 1.28685643 |
| 71 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.28216091 |
| 72 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.27142084 |
| 73 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25613819 |
| 74 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.24631049 |
| 75 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.23962411 |
| 76 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.23090800 |
| 77 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.22715319 |
| 78 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.22210700 |
| 79 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22154392 |
| 80 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.21951053 |
| 81 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.21477721 |
| 82 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.21087843 |
| 83 | ERA_21632823_ChIP-Seq_H3396_Human | 1.20954551 |
| 84 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.19606013 |
| 85 | FUS_26573619_Chip-Seq_HEK293_Human | 1.19484314 |
| 86 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.19041524 |
| 87 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.18915347 |
| 88 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.18702409 |
| 89 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.18398220 |
| 90 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.18355329 |
| 91 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.18355329 |
| 92 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.18206261 |
| 93 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.18019660 |
| 94 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.17017214 |
| 95 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.16967813 |
| 96 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.16381582 |
| 97 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.15830589 |
| 98 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.13489754 |
| 99 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.13385813 |
| 100 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.13367196 |
| 101 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.13345186 |
| 102 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.13315067 |
| 103 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.12796242 |
| 104 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11336053 |
| 105 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.10556489 |
| 106 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.10088099 |
| 107 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.09991219 |
| 108 | * P68_20966046_ChIP-Seq_HELA_Human | 1.09989784 |
| 109 | STAT3_23295773_ChIP-Seq_U87_Human | 1.08819611 |
| 110 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.08660021 |
| 111 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08279895 |
| 112 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.07911441 |
| 113 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.07620195 |
| 114 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.07620195 |
| 115 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.07524663 |
| 116 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.06827073 |
| 117 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.06302975 |
| 118 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.05152320 |
| 119 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.05131411 |
| 120 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.04579313 |
| 121 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.04283723 |
| 122 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.04203489 |
| 123 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.04187048 |
| 124 | ATF3_27146783_Chip-Seq_COLON_Human | 1.03792467 |
| 125 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.03773724 |
| 126 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.03701612 |
| 127 | CBP_21632823_ChIP-Seq_H3396_Human | 1.03199917 |
| 128 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.03065708 |
| 129 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03038733 |
| 130 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.02851214 |
| 131 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01309742 |
| 132 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.00918746 |
| 133 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.00880857 |
| 134 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.00826255 |
| 135 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.00779218 |
| 136 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.00485192 |
| 137 | * NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.99952251 |
| 138 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99555821 |
| 139 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.99203372 |
| 140 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.99187622 |
| 141 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.99076006 |
| 142 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.98997498 |
| 143 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.98919584 |
| 144 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.98524560 |
| 145 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.98419939 |
| 146 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.97843428 |
| 147 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.97795847 |
| 148 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.97727576 |
| 149 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97611891 |
| 150 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.97525268 |
| 151 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.96830225 |
| 152 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.96675844 |
| 153 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.96488606 |
| 154 | NCOR_22424771_ChIP-Seq_293T_Human | 0.96454577 |
| 155 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.95620704 |
| 156 | VDR_22108803_ChIP-Seq_LS180_Human | 0.95521231 |
| 157 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.94903763 |
| 158 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.91391830 |
| 159 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.90722158 |
| 160 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.90719341 |
| 161 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.90024078 |
| 162 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89868128 |
| 163 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.88861177 |
| 164 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.88043533 |
| 165 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.87799602 |
| 166 | * FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.87640194 |
| 167 | SA1_27219007_Chip-Seq_Bcells_Human | 0.86555272 |
| 168 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.86131123 |
| 169 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.85847906 |
| 170 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.85808742 |
| 171 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.85387060 |
| 172 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.84983214 |
| 173 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.84202315 |
| 174 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.83493086 |
| 175 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.83185893 |
| 176 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.83060166 |
| 177 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.82894036 |
| 178 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.82587162 |
| 179 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.81581609 |
| 180 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.81199709 |
| 181 | AR_20517297_ChIP-Seq_VCAP_Human | 0.80381437 |
| 182 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.80283088 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005083_abnormal_biliary_tract | 9.53602448 |
| 2 | MP0001666_abnormal_nutrient_absorption | 9.30596843 |
| 3 | MP0005365_abnormal_bile_salt | 6.68060310 |
| 4 | MP0005220_abnormal_exocrine_pancreas | 6.50883185 |
| 5 | MP0003868_abnormal_feces_composition | 4.91347248 |
| 6 | MP0005084_abnormal_gallbladder_morpholo | 4.65986954 |
| 7 | MP0003787_abnormal_imprinting | 4.08404287 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 3.61303967 |
| 9 | MP0002163_abnormal_gland_morphology | 3.13489643 |
| 10 | MP0002837_dystrophic_cardiac_calcinosis | 3.07060231 |
| 11 | MP0005379_endocrine/exocrine_gland_phen | 3.00113444 |
| 12 | MP0003122_maternal_imprinting | 2.97102996 |
| 13 | MP0001664_abnormal_digestion | 2.92713078 |
| 14 | MP0003123_paternal_imprinting | 2.86442254 |
| 15 | MP0002909_abnormal_adrenal_gland | 2.73898661 |
| 16 | MP0002693_abnormal_pancreas_physiology | 2.73013785 |
| 17 | MP0008004_abnormal_stomach_pH | 2.50985304 |
| 18 | MP0003959_abnormal_lean_body | 2.50586267 |
| 19 | MP0008877_abnormal_DNA_methylation | 2.36080001 |
| 20 | MP0002139_abnormal_hepatobiliary_system | 1.95834972 |
| 21 | MP0005645_abnormal_hypothalamus_physiol | 1.86837756 |
| 22 | MP0002090_abnormal_vision | 1.85805361 |
| 23 | MP0001944_abnormal_pancreas_morphology | 1.82412786 |
| 24 | MP0004264_abnormal_extraembryonic_tissu | 1.81495285 |
| 25 | MP0003172_abnormal_lysosome_physiology | 1.74290859 |
| 26 | MP0006072_abnormal_retinal_apoptosis | 1.65604075 |
| 27 | MP0005448_abnormal_energy_balance | 1.61645910 |
| 28 | MP0004233_abnormal_muscle_weight | 1.61321143 |
| 29 | MP0003121_genomic_imprinting | 1.60894711 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 1.54183993 |
| 31 | MP0005451_abnormal_body_composition | 1.52903665 |
| 32 | MP0005332_abnormal_amino_acid | 1.52649816 |
| 33 | MP0002277_abnormal_respiratory_mucosa | 1.49307801 |
| 34 | MP0004019_abnormal_vitamin_homeostasis | 1.45400967 |
| 35 | MP0002118_abnormal_lipid_homeostasis | 1.42277702 |
| 36 | MP0003638_abnormal_response/metabolism_ | 1.38139613 |
| 37 | MP0000462_abnormal_digestive_system | 1.35200021 |
| 38 | MP0009046_muscle_twitch | 1.33029181 |
| 39 | MP0001984_abnormal_olfaction | 1.28522661 |
| 40 | MP0000470_abnormal_stomach_morphology | 1.27535578 |
| 41 | MP0009840_abnormal_foam_cell | 1.25465980 |
| 42 | MP0001873_stomach_inflammation | 1.23560424 |
| 43 | MP0003879_abnormal_hair_cell | 1.23473563 |
| 44 | MP0010234_abnormal_vibrissa_follicle | 1.22705198 |
| 45 | MP0002102_abnormal_ear_morphology | 1.22319454 |
| 46 | MP0005551_abnormal_eye_electrophysiolog | 1.18158356 |
| 47 | MP0005646_abnormal_pituitary_gland | 1.17509357 |
| 48 | MP0003011_delayed_dark_adaptation | 1.12401230 |
| 49 | MP0005165_increased_susceptibility_to | 1.11968241 |
| 50 | MP0003806_abnormal_nucleotide_metabolis | 1.09939217 |
| 51 | MP0005408_hypopigmentation | 1.09319727 |
| 52 | MP0002078_abnormal_glucose_homeostasis | 1.06788147 |
| 53 | MP0009643_abnormal_urine_homeostasis | 1.04518745 |
| 54 | MP0000427_abnormal_hair_cycle | 1.03087284 |
| 55 | MP0002166_altered_tumor_susceptibility | 0.96932541 |
| 56 | MP0000003_abnormal_adipose_tissue | 0.96821448 |
| 57 | MP0005367_renal/urinary_system_phenotyp | 0.94281429 |
| 58 | MP0000516_abnormal_urinary_system | 0.94281429 |
| 59 | MP0005058_abnormal_lysosome_morphology | 0.94221631 |
| 60 | MP0000490_abnormal_crypts_of | 0.91812814 |
| 61 | MP0005535_abnormal_body_temperature | 0.88771328 |
| 62 | MP0001764_abnormal_homeostasis | 0.84003773 |
| 63 | MP0003252_abnormal_bile_duct | 0.83583059 |
| 64 | MP0009384_cardiac_valve_regurgitation | 0.83571811 |
| 65 | MP0002971_abnormal_brown_adipose | 0.82745138 |
| 66 | MP0003953_abnormal_hormone_level | 0.82173813 |
| 67 | MP0010352_gastrointestinal_tract_polyps | 0.79244440 |
| 68 | MP0002638_abnormal_pupillary_reflex | 0.79023957 |
| 69 | MP0001986_abnormal_taste_sensitivity | 0.78922154 |
| 70 | MP0002160_abnormal_reproductive_system | 0.78746401 |
| 71 | MP0001727_abnormal_embryo_implantation | 0.78670730 |
| 72 | MP0003186_abnormal_redox_activity | 0.78404619 |
| 73 | MP0006036_abnormal_mitochondrial_physio | 0.78071988 |
| 74 | MP0005360_urolithiasis | 0.77697702 |
| 75 | MP0002138_abnormal_hepatobiliary_system | 0.74987798 |
| 76 | MP0004270_analgesia | 0.73609008 |
| 77 | MP0005174_abnormal_tail_pigmentation | 0.71340542 |
| 78 | MP0004924_abnormal_behavior | 0.71114509 |
| 79 | MP0005386_behavior/neurological_phenoty | 0.71114509 |
| 80 | MP0008438_abnormal_cutaneous_collagen | 0.70799344 |
| 81 | MP0000569_abnormal_digit_pigmentation | 0.70673456 |
| 82 | MP0010329_abnormal_lipoprotein_level | 0.70324063 |
| 83 | MP0005253_abnormal_eye_physiology | 0.69528982 |
| 84 | MP0005389_reproductive_system_phenotype | 0.68891581 |
| 85 | MP0010678_abnormal_skin_adnexa | 0.68719230 |
| 86 | MP0001663_abnormal_digestive_system | 0.68237198 |
| 87 | MP0005452_abnormal_adipose_tissue | 0.68096936 |
| 88 | MP0001502_abnormal_circadian_rhythm | 0.67135960 |
| 89 | MP0002132_abnormal_respiratory_system | 0.66766961 |
| 90 | MP0006054_spinal_hemorrhage | 0.66519386 |
| 91 | MP0003633_abnormal_nervous_system | 0.66148915 |
| 92 | MP0004043_abnormal_pH_regulation | 0.64538629 |
| 93 | MP0002938_white_spotting | 0.64070272 |
| 94 | MP0002876_abnormal_thyroid_physiology | 0.63033097 |
| 95 | MP0008789_abnormal_olfactory_epithelium | 0.62257716 |
| 96 | MP0002557_abnormal_social/conspecific_i | 0.62079569 |
| 97 | MP0002272_abnormal_nervous_system | 0.61639433 |
| 98 | MP0004885_abnormal_endolymph | 0.61205993 |
| 99 | MP0000613_abnormal_salivary_gland | 0.60046468 |
| 100 | MP0004134_abnormal_chest_morphology | 0.59753725 |
| 101 | MP0000639_abnormal_adrenal_gland | 0.58961225 |
| 102 | MP0005266_abnormal_metabolism | 0.57648702 |
| 103 | MP0003567_abnormal_fetal_cardiomyocyte | 0.57184757 |
| 104 | MP0000598_abnormal_liver_morphology | 0.57046822 |
| 105 | MP0008961_abnormal_basal_metabolism | 0.55382833 |
| 106 | MP0009765_abnormal_xenobiotic_induced | 0.53620108 |
| 107 | MP0005381_digestive/alimentary_phenotyp | 0.53593534 |
| 108 | MP0005319_abnormal_enzyme/_coenzyme | 0.52633628 |
| 109 | MP0000609_abnormal_liver_physiology | 0.52144040 |
| 110 | MP0002928_abnormal_bile_duct | 0.50004424 |
| 111 | MP0005375_adipose_tissue_phenotype | 0.49284832 |
| 112 | MP0002098_abnormal_vibrissa_morphology | 0.48395263 |
| 113 | MP0001731_abnormal_postnatal_growth | 0.46232571 |
| 114 | MP0001845_abnormal_inflammatory_respons | 0.45833622 |
| 115 | MP0005636_abnormal_mineral_homeostasis | 0.45567128 |
| 116 | MP0000750_abnormal_muscle_regeneration | 0.44872825 |
| 117 | MP0005334_abnormal_fat_pad | 0.41395025 |
| 118 | MP0001756_abnormal_urination | 0.41140942 |
| 119 | MP0002089_abnormal_postnatal_growth/wei | 0.40685623 |
| 120 | MP0005394_taste/olfaction_phenotype | 0.40385974 |
| 121 | MP0005499_abnormal_olfactory_system | 0.40385974 |
| 122 | MP0003795_abnormal_bone_structure | 0.39113334 |
| 123 | MP0003183_abnormal_peptide_metabolism | 0.38452340 |
| 124 | MP0003656_abnormal_erythrocyte_physiolo | 0.38224575 |
| 125 | MP0000367_abnormal_coat/_hair | 0.38114070 |
| 126 | MP0000371_diluted_coat_color | 0.37747983 |
| 127 | MP0004185_abnormal_adipocyte_glucose | 0.37361178 |
| 128 | MP0009642_abnormal_blood_homeostasis | 0.36112763 |
| 129 | MP0002060_abnormal_skin_morphology | 0.35561271 |
| 130 | MP0010386_abnormal_urinary_bladder | 0.35429732 |
| 131 | MP0002796_impaired_skin_barrier | 0.35354732 |
| 132 | MP0001765_abnormal_ion_homeostasis | 0.33522319 |
| 133 | MP0000377_abnormal_hair_follicle | 0.32169540 |
| 134 | MP0000013_abnormal_adipose_tissue | 0.32016411 |
| 135 | MP0009333_abnormal_splenocyte_physiolog | 0.30962299 |
| 136 | MP0003283_abnormal_digestive_organ | 0.29017309 |
| 137 | MP0002069_abnormal_eating/drinking_beha | 0.28776304 |
| 138 | MP0003195_calcinosis | 0.28113797 |
| 139 | MP0008872_abnormal_physiological_respon | 0.27816766 |
| 140 | MP0001348_abnormal_lacrimal_gland | 0.26270324 |
| 141 | MP0000647_abnormal_sebaceous_gland | 0.25212668 |
| 142 | MP0008469_abnormal_protein_level | 0.23344774 |
| 143 | MP0003956_abnormal_body_size | 0.23126186 |
| 144 | MP0003329_amyloid_beta_deposits | 0.22799154 |
| 145 | MP0003693_abnormal_embryo_hatching | 0.21513182 |
| 146 | MP0002970_abnormal_white_adipose | 0.21218917 |
| 147 | MP0006035_abnormal_mitochondrial_morpho | 0.19469340 |
| 148 | MP0000358_abnormal_cell_content/ | 0.19203179 |
| 149 | MP0009780_abnormal_chondrocyte_physiolo | 0.19121197 |
| 150 | MP0001186_pigmentation_phenotype | 0.18660151 |
| 151 | MP0008875_abnormal_xenobiotic_pharmacok | 0.17659167 |
| 152 | MP0001661_extended_life_span | 0.17176791 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Steatorrhea (HP:0002570) | 7.91484288 |
| 2 | Gout (HP:0001997) | 6.68592510 |
| 3 | Fat malabsorption (HP:0002630) | 6.59824089 |
| 4 | Short chin (HP:0000331) | 6.05256378 |
| 5 | Symptomatic seizures (HP:0011145) | 6.04856138 |
| 6 | Decreased subcutaneous fat (HP:0001002) | 5.86538343 |
| 7 | Abnormality of subcutaneous fat tissue (HP:0001001) | 5.33788725 |
| 8 | Type I diabetes mellitus (HP:0100651) | 5.28200867 |
| 9 | Hypomagnesemia (HP:0002917) | 5.07339926 |
| 10 | Abnormality of the intrinsic pathway (HP:0010989) | 5.07273442 |
| 11 | Maternal diabetes (HP:0009800) | 4.63575500 |
| 12 | Exocrine pancreatic insufficiency (HP:0001738) | 4.58529999 |
| 13 | Pancreatic islet-cell hyperplasia (HP:0004510) | 4.50672794 |
| 14 | Large for gestational age (HP:0001520) | 4.49548359 |
| 15 | Prominent metopic ridge (HP:0005487) | 4.48574338 |
| 16 | Hypoplasia of the pons (HP:0012110) | 4.40280376 |
| 17 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.39021433 |
| 18 | Insulin-resistant diabetes mellitus (HP:0000831) | 4.24723180 |
| 19 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.24395430 |
| 20 | Abnormality of the pons (HP:0007361) | 4.17747796 |
| 21 | Abnormality of magnesium homeostasis (HP:0004921) | 4.10695515 |
| 22 | Hyperglycinemia (HP:0002154) | 4.01324215 |
| 23 | Abnormality of the metopic suture (HP:0005556) | 3.96899793 |
| 24 | Increased circulating renin level (HP:0000848) | 3.95166377 |
| 25 | Tubulointerstitial nephritis (HP:0001970) | 3.94693812 |
| 26 | Ketosis (HP:0001946) | 3.91336191 |
| 27 | Pancreatitis (HP:0001733) | 3.87326289 |
| 28 | Ketoacidosis (HP:0001993) | 3.73562799 |
| 29 | Joint stiffness (HP:0001387) | 3.68459147 |
| 30 | Hypothermia (HP:0002045) | 3.66358977 |
| 31 | Premature skin wrinkling (HP:0100678) | 3.63421450 |
| 32 | Abnormal pancreas size (HP:0012094) | 3.62763826 |
| 33 | Hyperglycinuria (HP:0003108) | 3.56792528 |
| 34 | Cortical dysplasia (HP:0002539) | 3.56481565 |
| 35 | Carpal bone hypoplasia (HP:0001498) | 3.51033708 |
| 36 | EEG with generalized epileptiform discharges (HP:0011198) | 3.44318080 |
| 37 | Epileptiform EEG discharges (HP:0011182) | 3.34298367 |
| 38 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.29052587 |
| 39 | Abnormality of glycine metabolism (HP:0010895) | 3.29052587 |
| 40 | Hypsarrhythmia (HP:0002521) | 3.26189268 |
| 41 | Enlarged penis (HP:0000040) | 3.24698911 |
| 42 | Hyperuricemia (HP:0002149) | 3.20153594 |
| 43 | Increased purine levels (HP:0004368) | 3.20153594 |
| 44 | Long foot (HP:0001833) | 3.19218585 |
| 45 | Tubulointerstitial fibrosis (HP:0005576) | 3.13420094 |
| 46 | Abnormal protein glycosylation (HP:0012346) | 3.11455335 |
| 47 | Abnormal glycosylation (HP:0012345) | 3.11455335 |
| 48 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.11455335 |
| 49 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.11455335 |
| 50 | Hypoglycemic coma (HP:0001325) | 3.07542467 |
| 51 | Hypoproteinemia (HP:0003075) | 3.02663174 |
| 52 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.00188255 |
| 53 | Vacuolated lymphocytes (HP:0001922) | 2.98950362 |
| 54 | Hypokinesia (HP:0002375) | 2.95137711 |
| 55 | Hyperphosphatemia (HP:0002905) | 2.93677562 |
| 56 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.91081940 |
| 57 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.91081940 |
| 58 | Optic nerve hypoplasia (HP:0000609) | 2.77894524 |
| 59 | Hypobetalipoproteinemia (HP:0003563) | 2.77701580 |
| 60 | Abnormality of the common coagulation pathway (HP:0010990) | 2.76611364 |
| 61 | Progressive muscle weakness (HP:0003323) | 2.74385662 |
| 62 | Prenatal maternal abnormality (HP:0002686) | 2.67511494 |
| 63 | Sex reversal (HP:0012245) | 2.66163722 |
| 64 | Abnormal sex determination (HP:0012244) | 2.66163722 |
| 65 | Insulin resistance (HP:0000855) | 2.63157376 |
| 66 | Megaloblastic anemia (HP:0001889) | 2.60185740 |
| 67 | Reduced antithrombin III activity (HP:0001976) | 2.57704653 |
| 68 | Abnormal number of erythroid precursors (HP:0012131) | 2.57578847 |
| 69 | Hypoglycemic seizures (HP:0002173) | 2.55626591 |
| 70 | Retinal atrophy (HP:0001105) | 2.54183711 |
| 71 | Methylmalonic aciduria (HP:0012120) | 2.52988525 |
| 72 | Abnormal tarsal ossification (HP:0008369) | 2.49726551 |
| 73 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.48867939 |
| 74 | Hyperthyroidism (HP:0000836) | 2.45211696 |
| 75 | Prolonged partial thromboplastin time (HP:0003645) | 2.43555611 |
| 76 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.42973778 |
| 77 | Dysostosis multiplex (HP:0000943) | 2.39534944 |
| 78 | Acute hepatic failure (HP:0006554) | 2.39503409 |
| 79 | Neoplasm of the adrenal cortex (HP:0100641) | 2.39497079 |
| 80 | Fatigue (HP:0012378) | 2.38707315 |
| 81 | Tubular atrophy (HP:0000092) | 2.38511146 |
| 82 | Testicular neoplasm (HP:0010788) | 2.37295815 |
| 83 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.35016864 |
| 84 | Muscular hypotonia of the trunk (HP:0008936) | 2.30331107 |
| 85 | Polydipsia (HP:0001959) | 2.29331557 |
| 86 | Abnormal drinking behavior (HP:0030082) | 2.29331557 |
| 87 | Pectus carinatum (HP:0000768) | 2.28996329 |
| 88 | Renal salt wasting (HP:0000127) | 2.28857613 |
| 89 | Abnormality of methionine metabolism (HP:0010901) | 2.27278441 |
| 90 | Tongue fasciculations (HP:0001308) | 2.26934417 |
| 91 | Hypoplasia of the odontoid process (HP:0003311) | 2.26629440 |
| 92 | Abnormality of purine metabolism (HP:0004352) | 2.23410100 |
| 93 | Tetany (HP:0001281) | 2.20810682 |
| 94 | Small epiphyses (HP:0010585) | 2.20322583 |
| 95 | Acute encephalopathy (HP:0006846) | 2.19912946 |
| 96 | Dicarboxylic aciduria (HP:0003215) | 2.17644705 |
| 97 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.17644705 |
| 98 | Opisthotonus (HP:0002179) | 2.17091783 |
| 99 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.16156504 |
| 100 | Downturned corners of mouth (HP:0002714) | 2.15915763 |
| 101 | Late onset (HP:0003584) | 2.15742473 |
| 102 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.15643624 |
| 103 | Cortical visual impairment (HP:0100704) | 2.13001683 |
| 104 | Abnormality of homocysteine metabolism (HP:0010919) | 2.12540609 |
| 105 | Homocystinuria (HP:0002156) | 2.12540609 |
| 106 | Lethargy (HP:0001254) | 2.11286671 |
| 107 | Type I transferrin isoform profile (HP:0003642) | 2.09908568 |
| 108 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.09894896 |
| 109 | Ventricular fibrillation (HP:0001663) | 2.08675157 |
| 110 | Hematochezia (HP:0002573) | 2.07846089 |
| 111 | Congenital malformation of the right heart (HP:0011723) | 2.07401226 |
| 112 | Double outlet right ventricle (HP:0001719) | 2.07401226 |
| 113 | Beaking of vertebral bodies (HP:0004568) | 2.07150753 |
| 114 | Methylmalonic acidemia (HP:0002912) | 2.06016297 |
| 115 | Diminished movement (HP:0002374) | 2.04212930 |
| 116 | Conjunctival hamartoma (HP:0100780) | 2.03326938 |
| 117 | Abnormality of the renal cortex (HP:0011035) | 2.03233323 |
| 118 | Hyperammonemia (HP:0001987) | 2.03036178 |
| 119 | Congenital glaucoma (HP:0001087) | 2.02467199 |
| 120 | Hyperphosphaturia (HP:0003109) | 2.01786385 |
| 121 | Barrel-shaped chest (HP:0001552) | 2.01685292 |
| 122 | Type II lissencephaly (HP:0007260) | 2.01046356 |
| 123 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.99687774 |
| 124 | Cerebral edema (HP:0002181) | 1.98682946 |
| 125 | Lower limb hyperreflexia (HP:0002395) | 1.96829455 |
| 126 | Limb hypertonia (HP:0002509) | 1.96647136 |
| 127 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.95712632 |
| 128 | Hepatic necrosis (HP:0002605) | 1.94267637 |
| 129 | Abnormality of renin-angiotensin system (HP:0000847) | 1.91710060 |
| 130 | Myocardial infarction (HP:0001658) | 1.91331180 |
| 131 | Hyperglycemia (HP:0003074) | 1.90858268 |
| 132 | Tubulointerstitial abnormality (HP:0001969) | 1.90195760 |
| 133 | Large hands (HP:0001176) | 1.89944310 |
| 134 | Abnormality of serum amino acid levels (HP:0003112) | 1.89226063 |
| 135 | Glycosuria (HP:0003076) | 1.87592420 |
| 136 | Abnormality of urine glucose concentration (HP:0011016) | 1.87592420 |
| 137 | Tachypnea (HP:0002789) | 1.86999234 |
| 138 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.86725022 |
| 139 | Muscle fibrillation (HP:0010546) | 1.86150970 |
| 140 | Abnormality of renal excretion (HP:0011036) | 1.85787945 |
| 141 | Calf muscle hypertrophy (HP:0008981) | 1.85549053 |
| 142 | Redundant skin (HP:0001582) | 1.84846974 |
| 143 | Vascular calcification (HP:0004934) | 1.84566198 |
| 144 | Agitation (HP:0000713) | 1.84292234 |
| 145 | Hypoplasia of the uterus (HP:0000013) | 1.84235759 |
| 146 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.83725072 |
| 147 | Thoracic kyphosis (HP:0002942) | 1.83466034 |
| 148 | Basal ganglia calcification (HP:0002135) | 1.83067289 |
| 149 | Abnormality of vitamin B metabolism (HP:0004340) | 1.82648854 |
| 150 | Abnormality of the basal ganglia (HP:0002134) | 1.82263960 |
| 151 | Unilateral renal agenesis (HP:0000122) | 1.80426141 |
| 152 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.79557997 |
| 153 | Hamartoma of the eye (HP:0010568) | 1.72664623 |
| 154 | Albinism (HP:0001022) | 1.71155452 |
| 155 | Small for gestational age (HP:0001518) | 1.69268446 |
| 156 | Progressive macrocephaly (HP:0004481) | 1.66572372 |
| 157 | Xanthomatosis (HP:0000991) | 1.66514783 |
| 158 | Abnormality of vitamin metabolism (HP:0100508) | 1.66122954 |
| 159 | Cardiovascular calcification (HP:0011915) | 1.62566218 |
| 160 | Malnutrition (HP:0004395) | 1.62486276 |
| 161 | Progressive neurologic deterioration (HP:0002344) | 1.62364521 |
| 162 | Polyuria (HP:0000103) | 1.61660346 |
| 163 | Adrenal hypoplasia (HP:0000835) | 1.61181946 |
| 164 | Hemiparesis (HP:0001269) | 1.59479250 |
| 165 | Progressive hearing impairment (HP:0001730) | 1.57810398 |
| 166 | Abnormal urine phosphate concentration (HP:0012599) | 1.57645602 |
| 167 | Abnormal biliary tract morphology (HP:0012440) | 1.56438841 |
| 168 | Polyphagia (HP:0002591) | 1.56198605 |
| 169 | Poor suck (HP:0002033) | 1.55590967 |
| 170 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.55319965 |
| 171 | Septate vagina (HP:0001153) | 1.46138087 |
| 172 | Episodic fever (HP:0001954) | 1.45483636 |
| 173 | Nuclear cataract (HP:0100018) | 1.44700881 |
| 174 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.44382252 |
| 175 | Menstrual irregularities (HP:0000858) | 1.43717781 |
| 176 | Increased CSF protein (HP:0002922) | 1.43699376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.45338841 |
| 2 | EIF2AK3 | 4.62493582 |
| 3 | FGFR2 | 4.26617532 |
| 4 | MAP2K2 | 3.84893523 |
| 5 | TRIB3 | 3.14804101 |
| 6 | PKN2 | 2.73132582 |
| 7 | MST4 | 2.68872728 |
| 8 | FRK | 2.57548403 |
| 9 | FGFR3 | 2.54412826 |
| 10 | INSRR | 2.54095016 |
| 11 | IRAK3 | 2.15629291 |
| 12 | MAPKAPK3 | 2.14922963 |
| 13 | WNK4 | 2.01442940 |
| 14 | BCKDK | 10.3467774 |
| 15 | ZAP70 | 1.96985038 |
| 16 | NTRK3 | 1.95886186 |
| 17 | AKT3 | 1.81418827 |
| 18 | NLK | 1.77933192 |
| 19 | PHKG1 | 1.63111398 |
| 20 | PHKG2 | 1.63111398 |
| 21 | NME1 | 1.62624247 |
| 22 | NME2 | 1.60642206 |
| 23 | MAP2K1 | 1.52913461 |
| 24 | PAK2 | 1.51459267 |
| 25 | HIPK2 | 1.44632269 |
| 26 | SCYL2 | 1.44037174 |
| 27 | ADRBK2 | 1.42973137 |
| 28 | PAK3 | 1.40625395 |
| 29 | MAP3K12 | 1.40348025 |
| 30 | PDK2 | 1.33945836 |
| 31 | TRIM28 | 1.31536488 |
| 32 | TAOK3 | 1.30790440 |
| 33 | PIK3CG | 1.26967439 |
| 34 | PRKAA2 | 1.25285803 |
| 35 | GRK1 | 1.25223221 |
| 36 | STK3 | 1.20856518 |
| 37 | DYRK1A | 1.19332651 |
| 38 | TAOK1 | 1.16207191 |
| 39 | TRPM7 | 1.15597706 |
| 40 | ACVR1B | 1.14129445 |
| 41 | FLT3 | 1.10043694 |
| 42 | RPS6KB2 | 1.09282090 |
| 43 | EEF2K | 1.09148867 |
| 44 | PDGFRB | 1.05967898 |
| 45 | PIK3CA | 1.01575115 |
| 46 | BMPR1B | 0.97809141 |
| 47 | MAPK15 | 0.96734991 |
| 48 | STK39 | 0.94745040 |
| 49 | PTK6 | 0.93303091 |
| 50 | MAP3K4 | 0.92388315 |
| 51 | PDK3 | 0.92265328 |
| 52 | PDK4 | 0.92265328 |
| 53 | TNIK | 0.91363924 |
| 54 | LATS1 | 0.89677839 |
| 55 | PRKCE | 0.88726619 |
| 56 | CAMK1G | 0.88433620 |
| 57 | PRKCG | 0.87537160 |
| 58 | STK16 | 0.86345063 |
| 59 | IRAK2 | 0.85436376 |
| 60 | CAMK2D | 0.83960433 |
| 61 | CSNK1G1 | 0.82697285 |
| 62 | ERBB3 | 0.77256575 |
| 63 | CAMKK1 | 0.76189907 |
| 64 | MAP4K2 | 0.74350524 |
| 65 | MAP2K6 | 0.73799057 |
| 66 | STK24 | 0.72883911 |
| 67 | PNCK | 0.70986746 |
| 68 | BCR | 0.67976537 |
| 69 | STK11 | 0.61777735 |
| 70 | PRKCI | 0.61712935 |
| 71 | IRAK4 | 0.61265117 |
| 72 | SGK2 | 0.59566720 |
| 73 | MTOR | 0.59346116 |
| 74 | PINK1 | 0.57529813 |
| 75 | SIK1 | 0.56938923 |
| 76 | PDPK1 | 0.56834706 |
| 77 | RPS6KB1 | 0.56517830 |
| 78 | DYRK1B | 0.56169670 |
| 79 | CSNK1G3 | 0.55974264 |
| 80 | MAP3K2 | 0.55144798 |
| 81 | DAPK2 | 0.54947993 |
| 82 | TSSK6 | 0.54876067 |
| 83 | MYLK | 0.54042560 |
| 84 | CAMKK2 | 0.52942982 |
| 85 | TIE1 | 0.51174408 |
| 86 | PDK1 | 0.50972627 |
| 87 | PLK3 | 0.50215270 |
| 88 | CDK3 | 0.50133236 |
| 89 | NEK6 | 0.49948824 |
| 90 | ZAK | 0.48651292 |
| 91 | MST1R | 0.45776419 |
| 92 | CAMK1D | 0.45545226 |
| 93 | YES1 | 0.45425969 |
| 94 | RET | 0.44579109 |
| 95 | SGK494 | 0.44377449 |
| 96 | SGK223 | 0.44377449 |
| 97 | TGFBR2 | 0.43984595 |
| 98 | PRKCZ | 0.43912005 |
| 99 | IRAK1 | 0.43746416 |
| 100 | DAPK1 | 0.41142152 |
| 101 | MAPK12 | 0.40179464 |
| 102 | CSNK1A1L | 0.40130149 |
| 103 | DYRK2 | 0.38644864 |
| 104 | LRRK2 | 0.38218991 |
| 105 | CSNK1D | 0.37829399 |
| 106 | ADRBK1 | 0.36403892 |
| 107 | CSNK1G2 | 0.35912108 |
| 108 | SGK3 | 0.34674012 |
| 109 | OBSCN | 0.32212969 |
| 110 | FGFR4 | 0.31727093 |
| 111 | PRKG1 | 0.31561353 |
| 112 | MAPK3 | 0.31092311 |
| 113 | LIMK1 | 0.30518293 |
| 114 | PRKACB | 0.30282934 |
| 115 | EIF2AK1 | 0.29386173 |
| 116 | MKNK2 | 0.29288653 |
| 117 | MET | 0.28963519 |
| 118 | SGK1 | 0.27885347 |
| 119 | JAK1 | 0.27663589 |
| 120 | PRKCH | 0.27346627 |
| 121 | PRKCA | 0.26823077 |
| 122 | NUAK1 | 0.26719968 |
| 123 | PLK2 | 0.26217682 |
| 124 | MAP3K3 | 0.25648494 |
| 125 | BRAF | 0.25392172 |
| 126 | CASK | 0.25192113 |
| 127 | NTRK1 | 0.24664041 |
| 128 | IKBKB | 0.22845588 |
| 129 | RPS6KA1 | 0.22663164 |
| 130 | STK38L | 0.22620235 |
| 131 | PASK | 0.22103983 |
| 132 | ATM | 0.22038804 |
| 133 | PRKG2 | 0.21889473 |
| 134 | MAP2K7 | 0.21829961 |
| 135 | KSR2 | 0.20229289 |
| 136 | FER | 0.18991731 |
| 137 | MAPK11 | 0.18640143 |
| 138 | PRKAA1 | 0.18349345 |
| 139 | ABL1 | 0.17335407 |
| 140 | JAK2 | 0.17145650 |
| 141 | PRKD3 | 0.16669103 |
| 142 | PIM2 | 0.16039337 |
| 143 | STK38 | 0.15453669 |
| 144 | MAP3K9 | 0.15247956 |
| 145 | IGF1R | 0.13946399 |
| 146 | MAP3K8 | 0.13443282 |
| 147 | EPHA3 | 0.13052884 |
| 148 | CSNK1A1 | 0.12936876 |
| 149 | ILK | 0.12669104 |
| 150 | MAPK1 | 0.11220380 |
| 151 | WNK1 | 0.10425066 |
| 152 | BRSK2 | 0.10270973 |
| 153 | AKT1 | 0.08879995 |
| 154 | CSNK1E | 0.06703838 |
| 155 | GSK3A | 0.06503564 |
| 156 | EGFR | 0.06406439 |
| 157 | PRKD1 | 0.06256271 |
| 158 | PRKACA | 0.05876383 |
| 159 | CDK19 | 0.05319052 |
| 160 | MAP3K7 | 0.05285511 |
| 161 | WNK3 | 0.04960717 |
| 162 | PTK2 | 0.04073098 |
| 163 | CDK4 | 0.04007400 |
| 164 | MAP2K4 | 0.03510375 |
| 165 | MAP3K1 | 0.03494009 |
| 166 | DDR2 | 0.03092683 |
| 167 | TBK1 | 0.02432220 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pancreatic secretion_Homo sapiens_hsa04972 | 7.78461918 |
| 2 | Fat digestion and absorption_Homo sapiens_hsa04975 | 5.83763505 |
| 3 | Protein digestion and absorption_Homo sapiens_hsa04974 | 5.11015000 |
| 4 | Protein export_Homo sapiens_hsa03060 | 3.84915496 |
| 5 | Folate biosynthesis_Homo sapiens_hsa00790 | 3.24226183 |
| 6 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.09083620 |
| 7 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.93284812 |
| 8 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.75571004 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.67194063 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.38483600 |
| 11 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.37549084 |
| 12 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.36425905 |
| 13 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.29046132 |
| 14 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.26384670 |
| 15 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.16382139 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.05837092 |
| 17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.81374195 |
| 18 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.71947011 |
| 19 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.45625519 |
| 20 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.39061384 |
| 21 | Circadian rhythm_Homo sapiens_hsa04710 | 1.38608128 |
| 22 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.38604910 |
| 23 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.37514118 |
| 24 | Mineral absorption_Homo sapiens_hsa04978 | 1.33429460 |
| 25 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.33394311 |
| 26 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.20992269 |
| 27 | Other glycan degradation_Homo sapiens_hsa00511 | 1.14929103 |
| 28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.10762020 |
| 29 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.09831930 |
| 30 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.08614087 |
| 31 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.06690952 |
| 32 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.00897380 |
| 33 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.98815498 |
| 34 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.98369009 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.97776329 |
| 36 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.96985419 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.93312696 |
| 38 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.91754314 |
| 39 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.86916836 |
| 40 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.86714069 |
| 41 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.86263494 |
| 42 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.85496088 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.80084757 |
| 44 | Renin secretion_Homo sapiens_hsa04924 | 0.79624759 |
| 45 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.79553754 |
| 46 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.78858215 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.78726062 |
| 48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.75972390 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 0.75915242 |
| 50 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.73779781 |
| 51 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.73153392 |
| 52 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.70852915 |
| 53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.69829889 |
| 54 | Retinol metabolism_Homo sapiens_hsa00830 | 0.69578072 |
| 55 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.69261214 |
| 56 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69026605 |
| 57 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.68237226 |
| 58 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.67034853 |
| 59 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.66212527 |
| 60 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.64997573 |
| 61 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.64828209 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64162607 |
| 63 | Influenza A_Homo sapiens_hsa05164 | 0.63245911 |
| 64 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.61899898 |
| 65 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.60484526 |
| 66 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.59039666 |
| 67 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.58254966 |
| 68 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.58241048 |
| 69 | Insulin secretion_Homo sapiens_hsa04911 | 0.57192237 |
| 70 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.56034294 |
| 71 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.54050205 |
| 72 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.49945273 |
| 73 | Carbon metabolism_Homo sapiens_hsa01200 | 0.48527683 |
| 74 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.48318978 |
| 75 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.46912671 |
| 76 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.45919065 |
| 77 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.44597528 |
| 78 | Phototransduction_Homo sapiens_hsa04744 | 0.43994014 |
| 79 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43854464 |
| 80 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.43660227 |
| 81 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.43387637 |
| 82 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.42544759 |
| 83 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.40485925 |
| 84 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.39921857 |
| 85 | Sulfur relay system_Homo sapiens_hsa04122 | 0.39134565 |
| 86 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.36730480 |
| 87 | Lysine degradation_Homo sapiens_hsa00310 | 0.36710744 |
| 88 | Lysosome_Homo sapiens_hsa04142 | 0.35730655 |
| 89 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.35457179 |
| 90 | Parkinsons disease_Homo sapiens_hsa05012 | 0.34812807 |
| 91 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34673363 |
| 92 | Salivary secretion_Homo sapiens_hsa04970 | 0.33299493 |
| 93 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.32347555 |
| 94 | Legionellosis_Homo sapiens_hsa05134 | 0.31597989 |
| 95 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.31289151 |
| 96 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.31194855 |
| 97 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.31028942 |
| 98 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.29182940 |
| 99 | Alzheimers disease_Homo sapiens_hsa05010 | 0.28760610 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28092264 |
| 101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.27483638 |
| 102 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26858934 |
| 103 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.26322485 |
| 104 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.25768893 |
| 105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.25633534 |
| 106 | Peroxisome_Homo sapiens_hsa04146 | 0.24249553 |
| 107 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.23779253 |
| 108 | Histidine metabolism_Homo sapiens_hsa00340 | 0.22909413 |
| 109 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.22711064 |
| 110 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.21450852 |
| 111 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.20829668 |
| 112 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.20793717 |
| 113 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.19707287 |
| 114 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.19141582 |
| 115 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.17748146 |
| 116 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.13099377 |
| 117 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.12278061 |
| 118 | Galactose metabolism_Homo sapiens_hsa00052 | 0.11109732 |
| 119 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.10644865 |
| 120 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.08587405 |
| 121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.07649792 |
| 122 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.07567042 |
| 123 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.06746659 |
| 124 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.05184358 |
| 125 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.04199815 |
| 126 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.03421301 |
| 127 | Endometrial cancer_Homo sapiens_hsa05213 | 0.03271843 |
| 128 | Bile secretion_Homo sapiens_hsa04976 | 0.00595959 |
| 129 | Insulin resistance_Homo sapiens_hsa04931 | 0.00402605 |
| 130 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.00180926 |
| 131 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0274642 |
| 132 | Ribosome_Homo sapiens_hsa03010 | -0.0106506 |
| 133 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | -0.0047671 |

